SARS-CoV-2 (COVID-19) Beta Variant ( B.1.351, SA) Spike RBD Recombinant Protein | 21-825

SARS-CoV-2 (COVID-19) Beta Variant ( B.1.351, SA) Spike RBD Recombinant Protein | 21-825 | Gentaur UK, US & Europe Distribution

Tested Application: E

Application: This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only.

Tpredicted Molecular Weight: 225 amino acids (including His tag); 25506 Da

Physical State: Liquid

Buffer: 20 mM Hepes pH 7.5; 150 mM NaCl

Storage Condition: –80˚C. Avoid freeze-thaw cycles

Alternate Name: SARS-CoV-2 (COVID-19) Spike RBD Recombinnat Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein

Background: N/A

Shipping: Dry Ice

Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.

Source: HEK293 cells

Species: SARS-CoV-2 (COVID-19, 2019-nCoV) Spike RBD Protein

By Source: Human Cells

By Species: Other

Fusion Tag: C-terminal His tag

Sequence: sequence (aa 319 – 537), N501Y
C-terminal His tag

Bological Activity: not determined

Purity: >98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Indigo Agarose.